Number of Shares
1.35 Mil
Current Holdings Value*
$99.59 Mil
% of Portfolio
0.6%
Total Estimate Gain
$18.44 Mil
% of Total Estimate Gain
14.50%

T. Rowe Price Equity Income Fund's AstraZeneca PLC Holding Summary

As of 2025-03-31, T. Rowe Price Equity Income Fund held 1.35 Mil shares of AstraZeneca PLC(AZN), totaling $99.59 Mil. This investment constitutes 0.6% of their stock portfolio, and T. Rowe Price Equity Income Fund now holds 0.04% of the outstanding AstraZeneca PLC(AZN) stock.

The initial trade took place in 2021Q3. And since then T. Rowe Price Equity Income Fund has made 6 purchases of AZN, at an average price of $61.16, for a total of 2.08 Mil shares. In addition, there have been 1 sales at an average price of $72.34 for 725,000.00 shares. Based on historical transaction data and AZN's current price of $68.79, T. Rowe Price Equity Income Fund's estimated gain on his AZN holdings is $18.44 Mil, reflecting a 14.50% gain to date.

T. Rowe Price Equity Income Fund AZN ($68.79) Holding Chart

T. Rowe Price Equity Income Fund AZN ($68.79) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1